BioSpace News Archive

BioMidwest

Chicago to host SCCE’s 22nd Annual Compliance & Ethics Institute

Compliance and ethics professionals from around the globe will gather in Chicago October 2–5, 2023, for the 22nd Annual Compliance & Ethics Institute, the flagship conference of Society of Corporate Compliance and Ethics®.

June 12, 2023
·
2 min read
Biotech Bay

Spruce Biosciences Announces Acceptance of Abstract for Presentation at the Annual Meeting of the Endocrine Society (ENDO 2023)

Spruce Biosciences, Inc. announced that a submitted abstract was accepted for the 105th Annual Meeting of the Endocrine Society taking place June 15-18, 2023, in Chicago.

June 12, 2023
·
1 min read
Pharm Country

Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

Alvotech and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd., announced they have reached a settlement and license agreement with Johnson & Johnson concerning AVT04, Alvotech’s proposed biosimilar to Stelara® in the United States.

June 12, 2023
·
11 min read
Genetown

KalVista Pharmaceuticals Presents New Data at 2023 Meeting of the European Academy of Allergy and Clinical Immunology

KalVista Pharmaceuticals, Inc. announced that it presented data on sebetralstat and quality of life issues experienced by people living with hereditary angioedema at the 2023 Meeting of the European Academy of Allergy and Clinical Immunology in Hamburg, Germany.

June 12, 2023
·
6 min read
Pharm Country

Phathom Pharmaceuticals Announces FDA Acceptance of NDA Resubmission for Erosive GERD

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged that its New Drug Application (NDA) resubmission for vonoprazan, a novel first-in-class potassium-competitive acid blocker (PCAB).

June 12, 2023
·
5 min read
Genetown

Resonetics Names Todd Trapp as Chief Financial Officer

Resonetics, a leading medical contract design and manufacturing organization, announced that Todd Trapp has joined the company as Chief Financial Officer.

June 12, 2023
·
2 min read
Genetown

Enveric Biosciences to Present at H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”) today announced that Joseph Tucker, Ph.D., Chief Executive Officer, will deliver a virtual presentation at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference taking place on Monday, June 26, 2023.

June 12, 2023
·
4 min read
Business

Senda Biosciences Appoints Marc Wolfgang as Senior Vice President, Manufacturing

Senda Biosciences, Inc., a Flagship Pioneering company pioneering programmable medicines, announced the appointment of Marc Wolfgang as Senior Vice President, Manufacturing.

June 12, 2023
·
3 min read
Cyclo Therapeutics Announces Allowance of Patent from European Patent Office for Trappsol® Cyclo™ for Alzheimer’s Disease

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”) today announced that the Company received a Communication from the European Patent Office (EPO) regarding Cyclo Therapeutics’ European Patent Application No.19805439.7 titled, “Methods for Treating Alzheimer’s Disease.”

June 12, 2023
·
3 min read
BioForest

Many long COVID patients suffer from persistent inflammation, study finds

An overactive inflammatory response could be at the root of many long COVID cases, according to a new study from the Allen Institute and Fred Hutchinson Cancer Center.

June 12, 2023
·
5 min read